Proposed NIH Genetic Testing Registry Lacks Clarity, Understates Costs
Tuesday, November 1, 2011 - 21:00
in Health & Medicine
The Association for Molecular Pathology (AMP) submitted comments to the National Institutes of Health (NIH), in which the Association voiced concerns about the proposed Genetic Testing Registry (GTR) as currently designed, and requested that NIH take clarity and cost into consideration when designing a test registry.